Three hub genes, COL7A1, MSLN, and CHRDL1, were identified from 513 robust DEGs using a series of bioinformatics methods, which were significantly correlated with tumor-infiltrating monocytes as well as effective indicators of prognostic outcomes for LUSC patients. Here, MSLN is linked to neoplasm.